Tolerability and safety of vemurafenib, cetuximab combined with camrelizumab for BRAF V600E-mutated /MSS metastatic colorectal cancer

被引：2
|
作者：
Qiu, M. [1 ]
Wei, G. [1 ]
Leng, W. [1 ]
Cao, P. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, West China Sch Med, Dept Colorectal Canc Ctr, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1815
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624P
引用
收藏
页码：S446 / S446
页数：1
相关论文
共 50 条
  • [21] Vemurafenib Treatment of BRAF V600E-Mutated Malignant Peripheral Nerve Sheath Tumor
    Kaplan, Henry G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (12): : 1466 - 1470
  • [22] DRAMATIC RESPONSE OF A BRAF V600E-MUTATED PRIMARY CNS HISTIOCYTIC SARCOMA TO VEMURAFENIB
    Idbaih, Ahmed
    Mokhtari, Karima
    Emile, Jean-Francois
    Galanaud, Damien
    Belaid, Hayat
    de Bernard, Simon
    Benameur, Neila
    Barlog, Vlad-Ciprian
    Psimaras, Dimitri
    Donadieu, Jean
    Carpentier, Catherine
    Martin-Duverneuil, Nadine
    Haroche, Julien
    Feuvret, Loic
    Zahr, Noel
    Delattre, Jean-Yves
    Khe Hoang-Xuan
    NEUROLOGY, 2014, 83 (16) : 1478 - 1480
  • [23] Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF V600E-Mutated Thyroid Cancer
    Jeon, Youngkyung
    Park, Sehhoon
    Lee, Se-Hoon
    Kim, Tae Hyuk
    Kim, Sun Wook
    Ahn, Myung-Ju
    Jung, Hyun Ae
    Chung, Jae Hoon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (04): : 1270 - 1276
  • [24] Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: an early post-marketing phase vigilance study
    Sakata, Hidenori
    Murase, Maki
    Kato, Takeshi
    Yamaguchi, Kensei
    Sugihara, Kenichi
    Suzuki, Shigenobu
    Yoshino, Takayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (01) : 139 - 144
  • [25] Safety and efficacy of encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: A systematic review and single-arm meta-analysis
    Celso, D. S. G.
    Defante, M. L. R.
    Alzogaray, V.
    Torres, L. A.
    Lopes, A. C. Melo
    Bearse, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S29 - S29
  • [26] Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma
    de Almeida, Natalia Pinto
    Janosi, Agnes Judit
    Hong, Runyu
    Rajeh, Ahmad
    Nogueira, Fabio
    Szadai, Leticia
    Szeitz, Beata
    Pla Parada, Indira
    Doma, Viktoria
    Woldmar, Nicole
    Guedes, Jessica
    Ujfaludi, Zsuzsanna
    Bartha, Aron
    Kim, Yonghyo
    Welinder, Charlotte
    Baldetorp, Bo
    Kemeny, Lajos Vince
    Pahi, Zoltan
    Wan, Guihong
    Nguyen, Nga
    Pankotai, Tibor
    Gyorffy, Balazs
    Pawlowski, Krzysztof
    Horvatovich, Peter
    Szasz, Attila Marcell
    Sanchez, Aniel
    Kuras, Magdalena
    Murillo, Jimmy Rodriguez
    Betancourt, Lazaro
    Domont, Gilberto B.
    Semenov, Yevgeniy R.
    Yu, Kun-Hsing
    Kwon, Ho Jeong
    Nemeth, Istvan Balazs
    Fenyo, David
    Wieslander, Elisabet
    Marko-Varga, Gyorgy
    Gil, Jeovanis
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (07):
  • [27] Vemurafenib Response in 2 Patients With Posttransplant Refractory BRAF V600E-Mutated Multiple Myeloma
    Sharman, J. P.
    Chmielecki, J.
    Morosini, D.
    Palmer, G. A.
    Ross, J. S.
    Stephens, P. J.
    Stafl, J.
    Miller, V. A.
    Ali, S. M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : E161 - E163
  • [28] Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer
    Yukimoto, Ryohei
    Nishida, Naohiro
    Hata, Tsuyoshi
    Fujino, Shiki
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Takahashi, Hidekazu
    Uemura, Mamoru
    Satoh, Taroh
    Hirofumi, Yamamoto
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    CANCER SCIENCE, 2021, 112 (07) : 2884 - 2894
  • [29] Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria BERING CRC
    von der Heyde, E.
    Buerkle, D.
    Forstbauer, H.
    Huebner, G.
    Schmidt, B.
    Schroeder, J.
    Distelrath, A.
    Wierecky, J.
    Stuebs, P.
    Kisro, J.
    Welslau, M.
    Mueller-Huesmann, H.
    Goehler, T.
    Krammer-Steiner, B.
    Schwaner, I.
    Hering-Schubert, C.
    Gerger, A.
    Greil, R.
    Jacobasch, L.
    Reichenbach, F.
    Stintzing, S.
    Prager, G.
    ANNALS OF ONCOLOGY, 2022, 33 : S248 - S248
  • [30] Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy
    Lee, Eudocia Q.
    Ruland, Sandra
    LeBoeuf, Nicole R.
    Wen, Patrick Y.
    Santagata, Sandro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : E87 - E89
12345